SPL 2.11% 9.3¢ starpharma holdings limited

Tardiness in spl, page-5

  1. 2,255 Posts.
    lightbulb Created with Sketch. 325
    I am not sure about you guys, but I really think that SPL's communication with the market has gotten even worse this year.

    Zero explanation as to why Vivagel/Fluerstat has not yet hit shelves.

    It has caused me to start questioning just how accurate their research has been to date...... If the market for BV treatment is indeed SO LARGE, then why would a company that has licenced a product, got TGA approval and marketing approval not yet got the stuff on shelves???

    I would have thought that with such a "Market changing" product, it would be fastracked to sales to maximise the profits to be had???

    Sorry for the rant. I just f#cking hate watching this company flounder around while bots manipulate the SP and the rest of us just sit tight waiting for announcements.....
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.